The broad offering at DLA Piper spans expertise across regulatory, transactions, product liability and patent litigation. Birmingham-based practice head Richard Taylor assists clients ranging from multinationals to public bodies on issues such as IP licensing and procurement. Also in Birmingham, Ryan Harrison excels in advising on cross-border commercial agreements. Mark Dewar’s expertise extends to advising on risk across supply chains. In Leeds, IP and commercial law specialist Kate Black is further recommended.
L’éditorial du Legal 500
Clients clés
- Dechra Pharmaceuticals
- Cancer Research UK
- Medica Group plc
- Argenx
- QMD (Q Medical Devices)
- Anthony Nolan Trust
- International Health Partners
- Curasight
- Pfizer
- Medtronic
Points forts
- Advising Pfizer in the UK, highlights this year including advising Pfizer on its contractual arrangements with the EU for supply of the Covid vaccine.
- Advising FTSE100 global veterinary pharmaceuticals business Dechra Pharmaceuticals on the GBP4.46bn take private backed by EQT. .
- Advised on over 30 pro bono matters opened for Cancer Research UK, continuing our close pro bono partnership with CRUK. We are particularly proud of our work this year supporting CRUK’s Bowelbabe Fund and the legacy of the late Dame Deborah James.
Avocats
Responsable de la pratique
Richard Taylor
Autres avocats clés
Ryan Harrison; Mark Dewar; Tom Heylen; Teresa Hitchcock; Kate Black